The Effectiveness of Probiotic Supplements in Attention Deficit-Hyperactivity Disorder

Phase 3

Recruiting

• Conditions: Attention deficit-hyperactivity disorder.; Attention-deficit hyperactivity disorder, combined type; F90.2

• Registration Number: IRCT20211004052670N6
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Children with Attention Deficit-Hyperactive Disorder with 6 to 12 years old.
No change in treatment regimen during the last two months.
Consent to participate in the study.

Exclusion Criteria

Taking anti-depressant drugs, anti-psychotic drugs and mood stabilizers.
Children with anxiety (based on Hamilton Rating Scale for Depression) and with depression (based on Children Depression Inventory).
Children with Inflammatory Bowel Disease, Celiac disease and Irritable bowel syndrome.
Children with Diabetes.

Study & Design

• Study Type: interventional
• Study Design: Not specified